Guangdong Biolight Meditech Co., Ltd. (300246.SZ)
CNY 7.6
(-0.78%)
CNY 7.6
(-0.78%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.53 Billion CNY | 3.92% |
| 2022 | 2.43 Billion CNY | 41.83% |
| 2021 | 1.71 Billion CNY | 6.99% |
| 2020 | 1.6 Billion CNY | 67.16% |
| 2019 | 961.45 Million CNY | 4.72% |
| 2018 | 918.15 Million CNY | 14.74% |
| 2017 | 800.22 Million CNY | 16.55% |
| 2016 | 686.56 Million CNY | 18.24% |
| 2015 | 580.64 Million CNY | 11.88% |
| 2014 | 519 Million CNY | 10.03% |
| 2013 | 471.71 Million CNY | 8.82% |
| 2012 | 433.5 Million CNY | 9.34% |
| 2011 | 396.48 Million CNY | 209.73% |
| 2010 | 128.01 Million CNY | 23.82% |
| 2009 | 103.38 Million CNY | 31.86% |
| 2008 | 78.4 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.59 Billion CNY | 0.59% |
| 2024 Q3 | 2.49 Billion CNY | -3.59% |
| 2024 Q1 | 2.57 Billion CNY | 1.61% |
| 2023 Q3 | 2.64 Billion CNY | 1.15% |
| 2023 FY | 2.53 Billion CNY | 3.92% |
| 2023 Q2 | 2.61 Billion CNY | 1.27% |
| 2023 Q4 | 2.53 Billion CNY | -4.29% |
| 2023 Q1 | 2.58 Billion CNY | 6.0% |
| 2022 Q3 | 2.22 Billion CNY | -3.65% |
| 2022 Q2 | 2.3 Billion CNY | 2.85% |
| 2022 Q1 | 2.24 Billion CNY | 30.29% |
| 2022 FY | 2.43 Billion CNY | 41.83% |
| 2022 Q4 | 2.43 Billion CNY | 9.86% |
| 2021 Q1 | 1.59 Billion CNY | -0.45% |
| 2021 FY | 1.71 Billion CNY | 6.99% |
| 2021 Q4 | 1.71 Billion CNY | 0.85% |
| 2021 Q3 | 1.7 Billion CNY | 3.4% |
| 2021 Q2 | 1.64 Billion CNY | 3.07% |
| 2020 Q1 | 1.05 Billion CNY | 9.79% |
| 2020 Q3 | 1.46 Billion CNY | 17.33% |
| 2020 Q4 | 1.6 Billion CNY | 9.81% |
| 2020 FY | 1.6 Billion CNY | 67.16% |
| 2020 Q2 | 1.24 Billion CNY | 18.18% |
| 2019 Q1 | 926.25 Million CNY | 0.88% |
| 2019 FY | 961.45 Million CNY | 4.72% |
| 2019 Q4 | 961.45 Million CNY | -9.81% |
| 2019 Q3 | 1.06 Billion CNY | 13.22% |
| 2019 Q2 | 941.51 Million CNY | 1.65% |
| 2018 Q3 | 897.25 Million CNY | 4.0% |
| 2018 Q4 | 918.15 Million CNY | 2.33% |
| 2018 Q2 | 862.78 Million CNY | 0.55% |
| 2018 FY | 918.15 Million CNY | 14.74% |
| 2018 Q1 | 858.07 Million CNY | 7.23% |
| 2017 Q4 | 800.22 Million CNY | 11.51% |
| 2017 Q3 | 717.62 Million CNY | 0.4% |
| 2017 Q2 | 714.75 Million CNY | 5.03% |
| 2017 Q1 | 680.54 Million CNY | -0.88% |
| 2017 FY | 800.22 Million CNY | 16.55% |
| 2016 Q1 | 618.95 Million CNY | 6.6% |
| 2016 FY | 686.56 Million CNY | 18.24% |
| 2016 Q4 | 686.56 Million CNY | 1.96% |
| 2016 Q3 | 673.39 Million CNY | 4.36% |
| 2016 Q2 | 645.26 Million CNY | 4.25% |
| 2015 Q3 | 574.15 Million CNY | 8.63% |
| 2015 Q2 | 528.53 Million CNY | 0.6% |
| 2015 Q1 | 525.39 Million CNY | 1.23% |
| 2015 FY | 580.64 Million CNY | 11.88% |
| 2015 Q4 | 580.64 Million CNY | 1.13% |
| 2014 Q1 | 476.98 Million CNY | 1.12% |
| 2014 Q2 | 480.58 Million CNY | 0.75% |
| 2014 FY | 519 Million CNY | 10.03% |
| 2014 Q4 | 519 Million CNY | 4.99% |
| 2014 Q3 | 494.33 Million CNY | 2.86% |
| 2013 Q4 | 471.71 Million CNY | -1.36% |
| 2013 FY | 471.71 Million CNY | 8.82% |
| 2013 Q3 | 478.22 Million CNY | 5.02% |
| 2013 Q2 | 455.35 Million CNY | 1.94% |
| 2013 Q1 | 446.7 Million CNY | 3.04% |
| 2012 Q1 | 402.83 Million CNY | 1.6% |
| 2012 Q3 | 430.5 Million CNY | 8.07% |
| 2012 Q4 | 433.5 Million CNY | 0.7% |
| 2012 FY | 433.5 Million CNY | 9.34% |
| 2012 Q2 | 398.35 Million CNY | -1.11% |
| 2011 Q3 | 385.45 Million CNY | 155.09% |
| 2011 Q2 | 151.1 Million CNY | 0.0% |
| 2011 FY | 396.48 Million CNY | 209.73% |
| 2011 Q4 | 396.48 Million CNY | 2.86% |
| 2010 FY | 128.01 Million CNY | 23.82% |
| 2010 Q4 | 128.01 Million CNY | 0.0% |
| 2009 FY | 103.38 Million CNY | 31.86% |
| 2008 FY | 78.4 Million CNY | 0.0% |